VS-4718 Antagonizes Multidrug Resistance in ABCB1- and ABCG2-Overexpressing Cancer Cells by Inhibiting the Efflux Function of ABC Transporters-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

VS-4718 Antagonizes Multidrug Resistance in ABCB1- and ABCG2-Overexpressing Cancer Cells by Inhibiting the Efflux Function of ABC Transporters

Published:2018-10-30 Issue: Volume:9 Page:
ISSN:1663-9812
Container-title:Frontiers in Pharmacology
language:
Short-container-title:Front. Pharmacol.

Author:

Ji Ning,Yang Yuqi,Cai Chao-Yun,Lei Zi-Ning,Wang Jing-Quan,Gupta Pranav,Teng Qiu-Xu,Chen Zhe-Sheng,Kong Dexin,Yang Dong-Hua

Publisher

Frontiers Media SA

Subject

Pharmacology (medical),Pharmacology

Reference46 articles.

1. Isolation and genetic characterization of human KB cell lines resistant to multiple drugs;Akiyama;Somat. Cell Mol. Genet.,1985

2. ABCB1 haplotypes but not individual SNPs predict for optimal response/failure in Egyptian patients with chronic-phase chronic myeloid leukemia receiving imatinib mesylate;Ali;Med. Oncol.,2014

3. Coexpression of multiple ABC-transporters is strongly associated with treatment response in childhood acute myeloid leukemia;Bartholomae;Pediatr. Blood Cancer,2016

4. Differential modulation of P-glycoprotein transport by protein kinase inhibition;Bates;Biochemistry,1993

5. A comprehensive study of polymorphisms in ABCB1, ABCC2 and ABCG2 and lung cancer chemotherapy response and prognosis;Campa;Int. J. Cancer,2012

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A novel FAK-degrading PROTAC molecule exhibited both anti-tumor activities and efficient MDR reversal effects;Acta Pharmacologica Sinica;2024-06-06

2. Targeting focal adhesion kinase (FAK) for cancer therapy: FAK inhibitors, FAK-based dual-target inhibitors and PROTAC degraders;Biochemical Pharmacology;2024-06

3. Prospects of focal adhesion kinase inhibitors as a cancer therapy in preclinical and early phase study;Expert Opinion on Investigational Drugs;2024-05-08

4. Discovery of 2,4-diarylaminopyrimidine derivatives bearing sulfonamide moiety as novel FAK inhibitors;Bioorganic Chemistry;2024-03

5. EGR1 mediates MDR1 transcriptional activity regulating gemcitabine resistance in pancreatic cancer;BMC Cancer;2024-02-26

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3